PMC:7283670 / 82273-82509 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T440","span":{"begin":40,"end":48},"obj":"Disease"},{"id":"T441","span":{"begin":59,"end":68},"obj":"Disease"},{"id":"T442","span":{"begin":137,"end":145},"obj":"Disease"},{"id":"T443","span":{"begin":146,"end":179},"obj":"Disease"}],"attributes":[{"id":"A440","pred":"mondo_id","subj":"T440","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A441","pred":"mondo_id","subj":"T441","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A442","pred":"mondo_id","subj":"T442","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A443","pred":"mondo_id","subj":"T443","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Hydroxychloroquine treatment for severe COVID‐19 pulmonary infection (HYDRA Trial) Drug: hydroxychloroquine, drug: placebo oral tablet COVID‐19 severe acute respiratory syndrome 500, all, 18–0 Treatment Active comparator: treatment"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T685","span":{"begin":191,"end":193},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T686","span":{"begin":208,"end":214},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Hydroxychloroquine treatment for severe COVID‐19 pulmonary infection (HYDRA Trial) Drug: hydroxychloroquine, drug: placebo oral tablet COVID‐19 severe acute respiratory syndrome 500, all, 18–0 Treatment Active comparator: treatment"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T324","span":{"begin":90,"end":108},"obj":"Chemical"},{"id":"T325","span":{"begin":110,"end":114},"obj":"Chemical"}],"attributes":[{"id":"A324","pred":"chebi_id","subj":"T324","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A325","pred":"chebi_id","subj":"T325","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Hydroxychloroquine treatment for severe COVID‐19 pulmonary infection (HYDRA Trial) Drug: hydroxychloroquine, drug: placebo oral tablet COVID‐19 severe acute respiratory syndrome 500, all, 18–0 Treatment Active comparator: treatment"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T715","span":{"begin":0,"end":236},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hydroxychloroquine treatment for severe COVID‐19 pulmonary infection (HYDRA Trial) Drug: hydroxychloroquine, drug: placebo oral tablet COVID‐19 severe acute respiratory syndrome 500, all, 18–0 Treatment Active comparator: treatment"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T244","span":{"begin":49,"end":68},"obj":"Phenotype"}],"attributes":[{"id":"A244","pred":"hp_id","subj":"T244","obj":"http://purl.obolibrary.org/obo/HP_0006532"}],"text":"Hydroxychloroquine treatment for severe COVID‐19 pulmonary infection (HYDRA Trial) Drug: hydroxychloroquine, drug: placebo oral tablet COVID‐19 severe acute respiratory syndrome 500, all, 18–0 Treatment Active comparator: treatment"}